ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0689

The Changing Epidemiology of Inpatient Gout and Associated Mortality: A 17-year National Study

Jasvinder Singh1 and John Cleveland1, 1University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2020

Keywords: Administrative Data, Epidemiology, gout, Health Services Research, Mortality

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Metabolic & Crystal Arthropathies Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Knowledge gaps exist regarding time-trends for the main causes (Cardiac/renal disease vs. infections) hospitalizations in gout. Therefore, we examined whether specific causes (cardiovascular, renal, musculoskeletal, pulmonary, infection) of non-gout hospitalizations and mortality, have changed over time in people with gout. 

Methods: We used the U.S. National Inpatient Sample (NIS) data from 1998 to 2014, the last calendar year with International Classification of Diseases, ninth revision, clinical modification (ICD-9-CM) in the U.S. NIS represents a 20% stratified sample of discharges for the U.S., a part of the Agency for Healthcare Research and Quality’s (AHRQ) healthcare cost and utilization project (HCUP).

Our study cohort included people hospitalized with a secondary diagnosis of gout based on an ICD-9-CM code, 274.xx, a valid approach with high sensitivity (90%), specificity (100%) and positive predictive value (80%). We assessed whether the rank (and % hospitalizations) of specific diseases in the top 25 Clinical Classifications Software (CCS; and top 5) categories associated with hospitalizations in gout changed between the first (1998-99) and the last study periods (2013-14). CCS is a tool for clustering patient diagnoses and procedures (primary or secondary) into manageable clinically meaningful categories [5]. We chose 2014 as the last study year, due to switching from ICD-9-CM to ICD-10-CM in 2015.

Results: Non-gout Hospitalizations in people with gout: There were 501,847 non-gout hospitalizations in 1998-99 and 1,665,355 in 2013-14. The top four CCS categories did not change rank from 1998-99 to 2013-14, but both top 2-ranked categories, circulatory system and heart diseases, decreased by 9-10%. Infection categories increased from three in the top 25 CCS categories in 1998-99 (rank # 11, 15 and 20) to five in 2013-14 (rank #10, 11, 12, 18 and 21; Figure 1A), and included pneumonia, respiratory infections, infections/parasitic diseases and sepsis. Musculoskeletal diseases were rank #5 for hospitalization in 2013-14 and osteoarthritis was also newly added to the top 25 ranks for non-gout hospitalizations.

In-hospital mortality: Circulatory system disease was rank #1 in both in 1998-99 and 2013-14, but the attributed proportion decreased from 40% to 29%. Two infection categories were in the top ten in 1998-99 (respiratory infection, rank #7; pneumonia, rank #8) versus four infection categories in the top five CCS categories in 2013-14 (rank #2, #3, #4 and #5; Figure 1B). Most cardiac diseases and neoplasms were less frequent, while infection, respiratory failure, renal disease were more frequent in 2013-14 (Figure 1B).

Conclusion:

Non-gout hospitalizations in people with gout increased over 2-decades. In-hospital mortality in patients with gout showed a replacement of cardiac/respiratory causes in ranks #2-5 in 1998-99 by infectious disease/sepsis in 2013-14. Cardiovascular diseases were the main reasons for non-gout hospitalizations in people with gout in both periods; but more importantly, their relative contribution decreased over 2-decades, while relative contributions of infectious and musculoskeletal diseases (including osteoarthritis) increased.

Figure 1. Top 25 healthcare cost and utilization project (HCUP) Clinical Classifications Software (CCS) category ranks based on diagnosis or procedures for hospitalizations (1A) and in-hospital death (1B) in people with gout comparing the first study (1998-1999) to the last study period (2013-2014) Figure 1 legend. Solid red arrows show the categories whose rank increased from 1998-1999 to 2013-2014, dashed green arrows whose rank decreased and solid black arrows with the same rank. Each CCS category label and category are shown in the first column. Square brackets refer to single-level CCS categories and regular brackets refer to multi-level CCS categories.

Figure 1B. See title and legend with the panel above


Disclosure: J. Singh, Crealta/Horizon, 1, Medisys, 1, Fidia, 1, UBM LLC, 1, Trio health, 1, Medscape, 1, WebMD, 1, Clinical Care options, 1, Clearview healthcare partners, 1, Putnam associates, 1, Focus forward, 1, Navigant consulting, 1, Spherix, 1, Practice Point communications, 1, the National Institutes of Health, 1, the American College of Rheumatology, 1, Amarin pharmaceuticals, 1, Viking therapeutics, 1, OMERACT, 1; J. Cleveland, None.

To cite this abstract in AMA style:

Singh J, Cleveland J. The Changing Epidemiology of Inpatient Gout and Associated Mortality: A 17-year National Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-changing-epidemiology-of-inpatient-gout-and-associated-mortality-a-17-year-national-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-changing-epidemiology-of-inpatient-gout-and-associated-mortality-a-17-year-national-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology